Citrobacter ventriculitis in a neonate responsive to trimethoprim-sulfamethoxazole

Clin Pediatr (Phila). 1983 Jul;22(7):515-7. doi: 10.1177/000992288302200711.

Abstract

There are increasing reports of citrobacter central nervous system infections in neonates. These organisms cause brain abcesses in a high percentage of patients. They may be resistant to commonly used antibiotics. We report a term male infant with underlying meningo-myelocoele and hydrocephalus in whom Citrobacter diversus meningitis and ventriculitis developed. Initial antibiotic therapy including intraventricular amikacin failed to sterilize the ventricles or alter a deteriorating clinical course. Adding intravenous trimethoprim-sulfamethoxazole to the therapeutic regimen resulted in reversal of a progressively worsening condition and eventual recovery. Trimethoprim-sulfamethoxazole should be considered as a potentially useful alternative antibiotic for susceptible central nervous system infections.

Publication types

  • Case Reports

MeSH terms

  • Amikacin / therapeutic use
  • Cerebral Ventricles / microbiology*
  • Citrobacter / isolation & purification
  • Drug Combinations / therapeutic use
  • Encephalitis / complications
  • Encephalitis / drug therapy*
  • Enterobacteriaceae Infections / drug therapy*
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases / drug therapy*
  • Male
  • Meningitis / complications
  • Meningitis / drug therapy*
  • Sulfamethoxazole / therapeutic use*
  • Trimethoprim / therapeutic use*
  • Trimethoprim, Sulfamethoxazole Drug Combination

Substances

  • Drug Combinations
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Amikacin
  • Trimethoprim
  • Sulfamethoxazole